Financial reports
10-K
2023 FY
Annual report
18 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
5 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
14 Mar 22
Current reports
8-K
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
13 Mar 24
8-K
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
8 Jan 24
8-K
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
13 Nov 23
8-K
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
26 May 23
8-K
Departure of Directors or Certain Officers
25 May 23
8-K
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
15 May 23
8-K
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
16 Mar 23
8-K
Entry into a Material Definitive Agreement
9 Feb 23
8-K
Entry into a Material Definitive Agreement
9 Jan 23
Registration and prospectus
S-8
Registration of securities for employees
18 Mar 24
S-3
Shelf registration
16 Mar 23
S-8
Registration of securities for employees
16 Mar 23
D
$53.62 mm in equity / options, sold $53.62 mm, 20 investors
28 Feb 23
S-8
Registration of securities for employees
14 Mar 22
424B5
Prospectus supplement for primary offering
25 Feb 22
S-3/A
Shelf registration (amended)
9 Feb 22
S-3
Shelf registration
30 Dec 21
S-8
Registration of securities for employees
22 Mar 21
S-8
Registration of securities for employees
9 Oct 20
Other
EFFECT
Notice of effectiveness
10 Apr 23
CORRESP
Correspondence with SEC
5 Apr 23
UPLOAD
Letter from SEC
21 Mar 23
EFFECT
Notice of effectiveness
14 Feb 22
CORRESP
Correspondence with SEC
9 Feb 22
UPLOAD
Letter from SEC
6 Jan 22
EFFECT
Notice of effectiveness
9 Oct 20
CERT
Certification of approval for exchange listing
6 Oct 20
CORRESP
Correspondence with SEC
6 Oct 20
CORRESP
Correspondence with SEC
6 Oct 20
Ownership
SC 13D/A
Novo Holdings A/S
25 Mar 24
4
Change in insider ownership
25 Mar 24
SC 13D/A
Novo Holdings A/S
20 Mar 24
4
Change in insider ownership
20 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
SC 13D/A
Novo Holdings A/S
18 Mar 24
4
Change in insider ownership
18 Mar 24
4
Ralph William Charlton III
18 Mar 24
4
Samir M. Gharib
18 Mar 24
4
Javier B. Szwarcberg
18 Mar 24